MELE Stock Analysis: Melexis | BR
Semiconductors | BR, Belgium | Market Cap: 2.099m EUR | 12M Return: 8.8% | BE0165385973 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.80M
EPS Trend: -95.2%
Qual. Beats: 0
Rev. Trend: -86.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Melexis NV is a Belgium-based semiconductor company that designs and markets integrated circuits, mainly for automotive applications. Its products include sensors for position, speed, pressure, temperature and tire monitoring, as well as motor-control, lighting and vehicle communication chips.
Founded in 1988 and headquartered in Ieper, Melexis serves customers across major global regions. Automotive semiconductors support functions such as vehicle sensing, control and connectivity.
- Automotive production swings drive sensor and actuator IC sales
- EV and ADAS adoption lifts semiconductor content per vehicle
- Pricing pressure and factory utilization shape gross margins
| Net Income: 107.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.29 > 0.02 and ΔFCF/TA 19.03 > 1.0 |
| NWC/Revenue: 51.73% < 20% (prev 56.84%; Δ -5.12% < -1%) |
| CFO/TA 0.34 > 3% & CFO 267.5m > Net Income 107.8m |
| Net Debt (209.5m) to EBITDA (196.4m): 1.07 < 3 |
| Current Ratio: 5.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.2m) vs 12m ago 0.60% < -2% |
| Gross Margin: 39.88% > 18% (prev 38.82%; Δ 1.07% > 0.5%) |
| Asset Turnover: 99.73% > 50% (prev 89.25%; Δ 10.48% > 0%) |
| Interest Coverage Ratio: 11.04 > 6 (EBIT TTM 144.5m / Interest Expense TTM 13.1m) |
| A: 0.56 (Total Current Assets 536.0m - Total Current Liabilities 92.5m) / Total Assets 797.7m |
| B: 0.66 (Retained Earnings 530.4m / Total Assets 797.7m) |
| C: 0.17 (EBIT TTM 144.5m / Avg Total Assets 859.6m) |
| D: 1.39 (Book Value of Equity 464.6m / Total Liabilities 333.2m) |
| Altman-Z'' = 8.41 = AAA |
| DSRI: 0.94 (Receivables 132.8m/136.0m, Revenue 857.4m/822.5m) |
| GMI: 0.97 (GM 38.82% / 39.88%) |
| AQI: 0.54 (AQ_t 0.08 / AQ_t-1 0.15) |
| SGI: 1.04 (Revenue 857.4m / 822.5m) |
| TATA: -0.20 (NI 107.8m - CFO 267.5m) / TA 797.7m) |
| Beneish M = -3.37 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at EUR 57.65 with a total of 72,197 shares traded. Over the past week, the price has changed by +9.81%, over one month by -7.76%, over three months by -18.83% and over the past year by +8.80%.
Current recommended Stop Loss: 53.90 (which is 6.5% or 1.8 ATR below the current price).
Melexis has no consensus analysts rating.
P/E Trailing = 20.0752
P/E Forward = 13.4048
P/S = 2.4481
P/B = 4.518
P/EG = 1.3702
Revenue TTM = 857.4m EUR
EBIT TTM = 144.5m EUR
EBITDA TTM = 196.4m EUR
Long Term Debt = 227.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 4.07m EUR (from shortTermDebt, last quarter)
Debt = 246.9m EUR (from shortLongTermDebtTotal, last quarter) + Leases 8.27m
Net Debt = 209.5m EUR (calculated: Debt 246.9m - CCE 37.4m)
Enterprise Value = 2.31b EUR (2.10b + Debt 246.9m - CCE 37.4m)
Interest Coverage Ratio = 11.04 (Ebit TTM 144.5m / Interest Expense TTM 13.1m)
EV/FCF = 9.94x (Enterprise Value 2.31b / FCF TTM 232.1m)
FCF Yield = 10.06% (FCF TTM 232.1m / Enterprise Value 2.31b)
FCF Margin = 27.08% (FCF TTM 232.1m / Revenue TTM 857.4m)
Net Margin = 12.57% (Net Income TTM 107.8m / Revenue TTM 857.4m)
Gross Margin = 39.88% ((Revenue TTM 857.4m - Cost of Revenue TTM 515.4m) / Revenue TTM)
Gross Margin QoQ = 40.71% (prev 40.51%)
Tobins Q-Ratio = 2.89 (Enterprise Value 2.31b / Total Assets 797.7m)
Interest Expense / Debt = 5.30% (Interest Expense 13.1m / Debt 246.9m)
Taxrate = 18.00% (23.7m / 131.4m)
NOPAT = 118.5m (EBIT 144.5m * (1 - 18.00%))
Current Ratio = 5.79 (Total Current Assets 536.0m / Total Current Liabilities 92.5m)
Debt / Equity = 0.53 (Debt 246.9m / totalStockholderEquity, last quarter 464.6m)
Debt / EBITDA = 1.07 (Net Debt 209.5m / EBITDA 196.4m)
Debt / FCF = 0.90 (Net Debt 209.5m / FCF TTM 232.1m)
Total Stockholder Equity = 471.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.54% (Net Income 107.8m / Total Assets 797.7m)
RoE = 22.88% (Net Income TTM 107.8m / Total Stockholder Equity 471.0m)
RoCE = 20.70% (EBIT 144.5m / Capital Employed (Equity 471.0m + L.T.Debt 227.3m))
RoIC = 17.64% (NOPAT 118.5m / Invested Capital 671.9m)
WACC = 9.15% (E(2.10b)/V(2.35b) * Re(9.72%) + D(246.9m)/V(2.35b) * Rd(5.30%) * (1-Tc(0.18)))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -35.49 | Cagr: -0.27%
[DCF] Terminal Value 75.41% ; FCFF base≈176.4m ; Y1≈202.2m ; Y5≈297.6m
[DCF] Fair Price = 94.48 (EV 3.92b - Net Debt 209.5m = Equity 3.71b / Shares 39.3m; r=9.15% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -95.16 | EPS CAGR: -26.98% | SUE: -0.36 | # QB: 0
Revenue Correlation: -86.80 | Revenue CAGR: -6.60% | SUE: -0.13 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.87 | Chg30d=-4.89% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.95 | Chg30d=-2.69% | Revisions=-42% | GrowthEPS=+6.0% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=3.83 | Chg30d=-0.37% | Revisions=+25% | GrowthEPS=+30.1% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: -5% (up=9, down=10)